Abstract
Proton pump inhibitors (PPIs) are widely prescribed for acid-peptic disease. In general, the safety of this class of drugs has been excellent. However, in the past several years, epidemiologic studies have indicated possible risks that are biologically plausible.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have